Position in CUE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$820
+$231 QoQ
Shares Held
26
-69.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 49 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CUE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. CUE ranks #366 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in CUE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $820 | 26 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $589 | 2,563 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $781 | 2,563 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $14,075 | 19,577 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $13,351 | 19,577 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $18,289 | 20,077 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $21,882 | 20,077 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $15,197 | 20,077 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $25,645 | 20,683 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $58,376 | 30,888 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $77,672 | 29,422 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $179,823 | 78,184 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $253,893 | 69,560 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $183,233 | 51,326 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $137,143 | 48,121 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $44,622 | 20,010 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $49,774 | 19,990 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $42,459 | 8,701 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $199,587 | 17,647 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,569 | 1,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,649 | 1,000 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $89,559 | 7,341 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $658,238 | 52,617 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $794,353 | 52,781 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,366,799 | 55,765 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $537,261 | 37,862 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||